Molecular Regulation of Human Placental Growth Factor ( PlGF ) Gene Expression in Placental Villi and Trophoblast Cells is Mediated via the Protein Kinase A Pathway
Restricted accessResearch articleFirst published online March, 2011
Molecular Regulation of Human Placental Growth Factor ( PlGF ) Gene Expression in Placental Villi and Trophoblast Cells is Mediated via the Protein Kinase A Pathway
Cyclic 3',5'-adenosine monophosphate (cAMP) is a critical second messenger for human trophoblasts and regulates the expression of numerous genes. It is known to stimulate in vitro the fusion and differentiation of BeWo choriocarcinoma cells, which acquire characteristics of syncytiotrophoblasts. A DNA microarray analysis of BeWo cells undergoing forskolin-induced syncytialization revealed that among the induced genes, placental growth factor (PlGF) was 10-fold upregulated. We verified this result in two choriocarcinoma cell lines, BeWo and JEG-3, and also in first trimester placental villous explants by quantifying PlGF mRNA (real time PCR) and PlGF protein secreted into the supernatant (ELISA). Similar effects were noted for vascular endothelial growth factor (VEGF) mRNA and protein expression. Treatment with cholera toxin and the use of a specific inhibitor of protein kinase A (PKA) blocked these effects, indicating that the cAMP/PKA pathway is responsible for the cAMP-induced upregulation of PlGF and that one or more G protein coupled receptor(s) was involved. We identified two functional cAMP responsive elements (CRE) in the PlGF promoter and demonstrated that the CRE binding protein, CREB, contributes to the regulation of PlGF gene expression. We speculate that defects in this signaling pathway may lead to abnormal secretion of PlGF protein as observed in the pregnancy-related diseases preeclampsia and intrauterine growth restriction.
DepoixCLTaylorRNPlacental Angiogenesis. In:
PijnenborgRBrosensIRomeroR eds. Placental Bed Vascular Disorders—basic Science and Clinical Management. Cambridge, UK: Cambridge University Press; 2010:52–62.
2.
ChangKLuboZ. Review article: steroid hormones and uterine vascular adaptation to pregnancy. Reprod Sci. 2008;15(4):336–348.
3.
MillerVMDucklesSP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008;60(2):210–241.
4.
QiaoXMcConnellKRKhalilRA. Sex steroids and vascular responses in hypertension and aging. Gend Med. 2008;5(suppl A):S46–S64.
5.
IraniRAXiaY. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta. 2008;29(9):763–771.
6.
KhakooAYSidmanRLPasqualiniRArapW. Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?. Cancer Res. 2008;68(22):9112–9115.
7.
WiceBMentonDGeuzeHSchwartzAL. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp Cell Res. 1990;186(2):306–316.
8.
TaylorRNNewmanEDChenSA. Forskolin and methotrexate induce an intermediate trophoblast phenotype in cultured human choriocarcinoma cells. Am J Obstet Gynecol. 1991;164(1 pt 1):204–210.
9.
PotgensAJDrewloSKokozidouMKaufmannP. Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action. Hum Reprod Update. 2004;10(6):487–496.
10.
KnerrISchubertSWWichC. Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions. FEBS Lett. 2005;579(18):3991–3998.
JamesonJLJaffeRCGleasonSLHabenerJF. Transcriptional regulation of chorionic gonadotropin alpha- and beta-subunit gene expression by 8-bromo-adenosine 3′,5′-monophosphate. Endocrinology. 1986;119(6):2560–2567.
13.
MendelsonCRKamatA. Mechanisms in the regulation of aromatase in developing ovary and placenta. J Steroid Biochem Mol Biol. 2007;106(1-5):62–70.
14.
HunterAAitkenheadMCaldwellCMcCrackenGWilsonDMcClureN. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension. 2000;36(6):965–969.
15.
TaylorRNGrimwoodJTaylorRSMcMasterMTFisherSJNorthRA. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol. 2003;188(1):177–182.
16.
LevineRJMaynardSEQianC. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
17.
LevineRJLamCQianC. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
18.
ClarkDESmithSKLicenceDEvansALCharnock-JonesDS. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol. 1998;159(3):459–467.
19.
KudoYBoydCASargentILRedmanCWLeeJMFreemanTC. An analysis using DNA microarray of the time course of gene expression during syncytialization of a human placental cell line (BeWo). Placenta. 2004;25(6):479–488.
20.
van den DriescheSMyersMGayEThongKJDuncanWC. HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Mol Hum Reprod. 2008;14(8):455–464.
21.
PopoviciRMIrwinJCGiacciaAJGiudiceLC. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J Clin Endocrinol Metab. 1999;84(6):2245–2248.
22.
RadonicAThulkeSMackayIMLandtOSiegertWNitscheA. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun. 2004;313(4):856–862.
23.
LieblichJMWeintraubBDKrauthGHKohlerPORabsonASRosenSW. Ectopic and eutopic secretion of chorionic gonadotropin and its subunits in vitro: comparison of clonal strains from carcinomas of lung and placenta. J Natl Cancer Inst. 1976;56(5):911–917.
24.
HamaiYFujiiTYamashitaT. The expression of human leukocyte antigen-G on trophoblasts abolishes the growth-suppressing effect of interleukin-2 towards them. Am J Reprod Immunol. 1999;41(2):153–158.
25.
WaiteLLPersonECZhouYLimKHScanlanTSTaylorRN. Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab. 2000;85(10):3808–3814.
26.
CarthariusKFrechKGroteK. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005;21(13):2933–2942.
27.
HagiwaraMBrindlePHarootunianA. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol. 1993;13(8):4852–4859.
28.
MayallTPSheridanPLMontminyMRJonesKA. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev. 1997;11(7):887–899.
29.
ChangMMukherjeaDGobbleRMGroeschKATorryRJTorryDS. Glial cell missing 1 regulates placental growth factor (PGF) gene transcription in human trophoblast. Biol Reprod. 2008;78(5):841–851.
30.
CramerMNagyIMurphyBJ. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem. 2005;386(9):865–872.
31.
HosoyaTTakizawaKNittaKHottaY. Glial cells missing: a binary switch between neuronal and glial determination in Drosophila. Cell. 1995;82(6):1025–1036.
32.
JonesBWFetterRDTearGGoodmanCS. Glial cells missing: a genetic switch that controls glial versus neuronal fate. Cell. 1995;82(6):1013–1023.
33.
AlfonsoTBJonesBW. Gcm2 promotes glial cell differentiation and is required with glial cells missing for macrophage development in Drosophila. Dev Biol. 2002;248(2):369–383.
34.
SchreiberJRiethmacher-SonnenbergERiethmacherD. Placental failure in mice lacking the mammalian homolog of glial cells missing, GCMa. Mol Cell Biol. 2000;20(7):2466–2474.
35.
ChangCWChuangHCYuCYaoTPChenH. Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. Mol Cell Biol. 2005;25(19):8401–8414.
36.
IimuroSShindoTMoriyamaN. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res. 2004;95(4):415–423.
37.
Ichikawa-ShindoYSakuraiTKamiyoshiA. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest. 2008;118(1):29–39.
38.
MakinoYShibataKMakinoIOnoYKangawaKKawarabayashiT. Expression of adrenomedullin in feto-placental circulation of human normotensive pregnant women and pregnancy-induced hypertensive women. Endocrinology. 1999;140(11):5439–5442.
39.
KnerrIDachertCBeinderE. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):47–53.
40.
DongYLGreenKEVegiraguS. Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J Clin Endocrinol Metab. 2005;90(4):2336–2343.
41.
DongYLChauhanMGreenKE. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol. 2006;195(6):1657–1667.
42.
Di IorioRMarinoniELetiziaCAloPVillaccioBCosmiEV. Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia. Hypertension. 1998;32(4):758–763.
43.
GrattonRJGluszynskiMMazzucaDMNygardKHanVK. Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2003;88(12):6048–6055.
44.
Di IorioRMarinoniELetiziaCGazzoloDLucchiniCCosmiEV. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. Am J Obstet Gynecol. 2000;182(3):650–654.
